-

McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.

“For the past five years, Bansi has been a critical member of our executive team and has played an important role in key acquisitions and the evolution of our strategy to reposition McKesson in a rapidly-evolving market,” said Brian Tyler, Chief Executive Officer, McKesson. “We are grateful for his many contributions which have strengthened our core business and created new areas of growth. With the recent completion of our successful exit from Change Healthcare, and in the context of the company’s headquarters move to Dallas, Bansi and I agreed that this was the right time for this transition. We appreciate Bansi’s commitment to remain with the company for an interim period to assist with the transition of his responsibilities and wish him all the best as he begins his successful next chapter.”

Prior to joining McKesson in 2015, Nagji served as a principal of Deloitte Consulting, LLP where he led the U.S. Strategy Service Line and the Global practice of Monitor Deloitte, which was formed by the global merger of Monitor Group with Deloitte in January 2013. He was instrumental in the integration of Monitor into Deloitte’s operations. Before the merger with Deloitte, Nagji was president of Monitor Group. Nagji has served on several boards, including Change Healthcare, Inc.

About McKesson Corporation

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

Contacts

Holly Weiss, 972-969-9174 (Investors)
Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com

McKesson Corporation

NYSE:MCK

Release Versions

Contacts

Holly Weiss, 972-969-9174 (Investors)
Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com

More News From McKesson Corporation

McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services. McKesson will acquire Precision Medicine Group for approximately $2.25 billion. Following completion of the transaction, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment. The transacti...

McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 5 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and ar...

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable on October 1, 2026, to shareholders of record on September 1, 2026. “Today’s announcement marks our tenth consecutive year of dividend growth, reflecting the strength of our business, our disciplined approach to capital allocation and our commitmen...
Back to Newsroom